Purpose: To report the clinical course of our first 7 consecutive patients treated with intravitreal ocriplasmin (Jetrea(®)).
Methods: Retrospective case series of the first 7 patients treated with ocriplasmin between January and December 2013 at an academic tertiary care center.
Results: The average age was 78.4 years (range: 63-92). Five patients were pseudophakic and 2 patients were phakic in the injected eye. The median baseline visual acuity (VA) was 20/60 (range: 20/25 to 20/200). The median 1-month postinjection VA was 20/70, with a mean loss of 2 lines of VA among all patients. None of the patients had complete resolution of their vitreomacular traction or macular hole at 1 month of follow-up. Three patients had subsequent pars plana vitrectomy and membrane peeling surgery. The mean follow-up period for those who did not undergo vitrectomy was 9 months (range: 1-13). One patient with known ocular hypertension had an increase in intraocular pressure requiring topical pressure-lowering eyedrops. There were no cases of postinjection uveitis, endophthalmitis, retinal tears, or retinal detachment.
Conclusions: While ocriplasmin may be a viable pharmacological agent for vitreolysis, we present a series of patients that all had incomplete resolution of vitreomacular traction with and without full-thickness macular hole. There was an associated reduction in VA after ocriplasmin treatment at 1 month of follow-up. Careful analysis of the vitreoretinal interface and comorbid eye conditions is required to optimize outcome success with ocriplasmin.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4296250 | PMC |
| http://dx.doi.org/10.1159/000370024 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Clinical Characteristics and Surgical Outcomes of the Full-thickness Macular Hole Without Focal Vitreomacular Traction: A Multicenter Retrospective Study.
Retina
December 2024
Department of Ophthalmology, Akita University, 44-2 Hasunuma, Akita, Akita Prefecture, Japan.
Purpose: This study investigated the clinical features and surgical outcomes of full-thickness macular holes (FTMHs) without focal vitreomacular traction (VMT) and discusses possible underlying mechanisms.
Methods: This was a retrospective observational study included patients aged 18 years or older with stage 2 FTMHs who underwent pars plana vitrectomy at three hospitals between December 2016 and March 2024. Patients diagnosed without focal VMT in the macula were classified as VMT- and those with focal VMT were classified as VMT+.
Presumed phototoxicity from macular vital staining with Brilliant Blue G and Trypan Blue: A post-market surveillance study, systematic review, and synthesis of the literature.
Surv Ophthalmol
November 2024
King's Ophthalmology Research Unit (KORU), King's College Hospital, London, United Kingdom; Faculty of Life Sciences and Medicine, King's College London, United Kingdom.
Article Synopsis
- * A study identified 69 cases of dye-related phototoxicity, mostly linked to vitrectomies for macular issues, although quantifying the risk is complicated due to possible bias in reporting.
- * Risk factors include longer surgeries and multiple dye applications, with consequences like changes in retinal pigmentation and poorer final visual acuity compared to pre-surgery levels; a new reporting template aims to standardize toxicity data.
The impact of vitreomacular traction on vitreous vascular endothelial growth factor and placental growth factor levels in neovascular age-related macular degeneration patients.
Eye (Lond)
November 2024
Ankara Training and Research Hospital, Department of Medical Biochemistry, Ankara, Turkey.
Purpose: To investigate the effect of vitreomacular traction (VMT) on vitreous vascular endothelial growth factor (VEGF) and placental growth factor (PlGF) levels in patients with active neovascular age-related macular degeneration (nAMD).
Design: A prospective, interventional, case-control study.
Methods: The study included a total of 70 patients from whom vitreous samples were obtained.
Macular Alterations in a Cohort of Caucasian Patients Affected by Retinitis Pigmentosa.
Diagnostics (Basel)
October 2024
Department of Sense Organs, Faculty of Medicine and Odontology, Sapienza University of Rome, p.le A. Moro 5, 00185 Rome, Italy.
Objectives: Our objective was to investigate the prevalence of macular complications detected by spectral-domain optical coherence tomography (SD-OCT) in a large Caucasian cohort of RP patients, highlight the major alterations in chorioretinal structure, and compare the macular structural changes in eyes affected by retinal dystrophies with those in healthy controls.
Methods: This was an observational, retrospective, and cross-sectional study. Three hundred and seven patients with RP were consecutively enrolled and underwent clinical assessment.
Intraretinal hyperreflective line: potential biomarker in various retinal disorders.
Med Hypothesis Discov Innov Ophthalmol
October 2024
Department of Ophthalmology, Dokuz Eylul University, Izmir, Turkey.
Article Synopsis
- The study investigates the intraretinal hyperreflective line (IHL), a new finding seen through optical coherence tomography (OCT) that suggests damage in the retina's layers due to various conditions.
- Through a retrospective analysis of records from 2019 to 2023, researchers identified IHLs in 40 eyes of 38 participants, noting its connection to various retinal diseases and prior surgeries.
- Key findings included the presence of IHL in 35% of eyes with prior vitreoretinal surgery, as well as associations with conditions like full-thickness macular holes, diabetic macular edema, and idiopathic macular telangiectasia.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!